Marex Group Limited
69.96USD
+1.4200 (+2.07%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MRX.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.54▲ | $1.23 | 3 | 0 |
| Next quarter | $1.55▲ | $1.31 | 3 | 0 |
| Current year | $6.18▲ | $5.16 | 3 | 0 |
| Next year | $6.66▲ | $5.77 | 4 | 0 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.36 | $1.64 | +0.28 (+20.4%) |
| 2026-03-31 | $1.38 | $1.48 | +0.10 (+7.1%) |
| 2025-12-31 | $1.02 | $1.13 | +0.11 (+10.5%) |
| 2025-09-30 | $0.94 | $0.96 | +0.02 (+2.5%) |
51 ratings from 10 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| William Blair | Initiated | Outperform | — | Oct 14, 2026 |
| Barclays | Maintained | Overweight | $86 $92 | Oct 7, 2026 |
| Piper Sandler | Maintained | Overweight | $75 $80 | Oct 2, 2026 |
| UBS | Maintained | Buy | $82 $90 | Aug 13, 2026 |
| Barclays | Maintained | Overweight | $76 $86 | Aug 13, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $80 $90 | Aug 13, 2026 |
| Jefferies | Maintained | Buy | $57 $80 | Jul 20, 2026 |
| Piper Sandler | Maintained | Overweight | $55 $75 | Jul 15, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $60 $80 | Jul 10, 2026 |
| Barclays | Maintained | Overweight | $60 $76 | Jul 9, 2026 |
| TD Cowen | Maintained | Buy | $67 $75 | Jun 8, 2026 |
| Barclays | Maintained | Overweight | $55 $60 | May 11, 2026 |
| TD Cowen | Maintained | Buy | $66 $67 | May 7, 2026 |
| UBS | Maintained | Buy | $56 $60 | Apr 2, 2026 |
| TD Cowen | Maintained | Buy | $61 $66 | Mar 27, 2026 |
| Barclays | Maintained | Overweight | $50 $55 | Mar 27, 2026 |
| Barclays | Maintained | Overweight | $49 $50 | Mar 4, 2026 |
| TD Cowen | Maintained | Buy | $54 $61 | Jan 14, 2026 |
| Piper Sandler | Maintained | Overweight | $50 $55 | Jan 14, 2026 |
| Barclays | Maintained | Overweight | $50 $49 | Jan 8, 2026 |
| Barclays | Maintained | Overweight | $43 $50 | Dec 12, 2025 |
| Goldman Sachs | Maintained | Buy | $47 $52 | Nov 7, 2025 |
| Barclays | Maintained | Overweight | $40 $43 | Nov 7, 2025 |
| Barclays | Maintained | Overweight | $50 $40 | Oct 8, 2025 |
| Barclays | Maintained | Overweight | $52 $50 | Aug 14, 2025 |
35 filings from 16 insiders · 10 buy / 17 sell over 6m
Officers and directors of MRX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Van Den Born SimonOfficer, President | Sell | 1.3k | $72.63 | $92k | Oct 12, 2026 |
| Van Den Born SimonOfficer, President | Sell | 14.0k | $71.99 | $1.01M | Oct 12, 2026 |
| Tonucci PaoloOfficer, See Remarks | Sell | 1.2k | $72.64 | $84k | Oct 12, 2026 |
| Tonucci PaoloOfficer, See Remarks | Sell | 15.5k | $71.98 | $1.12M | Oct 12, 2026 |
| Tonucci PaoloOfficer, See Remarks | Sell | 3.0k | $71.35 | $211k | Sep 14, 2026 |
| Tonucci PaoloOfficer, See Remarks | Sell | 13.7k | $70.77 | $971k | Sep 14, 2026 |
| Van Den Born SimonOfficer, President | Sell | 2.7k | $71.36 | $189k | Sep 14, 2026 |
| Van Den Born SimonOfficer, President | Sell | 12.6k | $70.77 | $893k | Sep 14, 2026 |
| Tonucci PaoloOfficer, See Remarks | Tax | 18.3k | $78.27 | $1.43M | Sep 7, 2026 |
| Van Den Born SimonOfficer, President | Tax | 13.2k | $78.27 | $1.03M | Sep 7, 2026 |
| Jethwa NileshOfficer, CEO, Marex Solutions | Tax | 31.6k | $78.27 | $2.47M | Sep 7, 2026 |
| Lowitt Ian TDirector; Officer, Chief Executive Officer | Tax | 36.6k | $78.27 | $2.86M | Sep 7, 2026 |
| LOWITT IAN TChief Executive Officer | Grant | 77.8k | — | — | Aug 19, 2026 |
| VAN DEN BORN SIMONPresident | Grant | 33.6k | — | — | Aug 19, 2026 |
| TONUCCI PAOLO ROBERTOOfficer | Grant | 38.9k | — | — | Aug 19, 2026 |
| JETHWA NILESH KUMAROfficer | Grant | 67.2k | — | — | Aug 19, 2026 |
| IRVIN CRISPIN ROBERT JOHNChief Financial Officer | Sell | 3.7k | $70.91 | $263k | Aug 14, 2026 |
| TONUCCI PAOLO ROBERTOOfficer | Sell | 16.7k | $60.64 | $1.02M | Aug 10, 2026 |
| LOWITT IAN TChief Executive Officer | Sell | 37.1k | $64.19 | $2.39M | Jul 13, 2026 |
| TONUCCI PAOLO ROBERTOOfficer | Sell | 16.7k | $64.22 | $1.07M | Jul 13, 2026 |
No analyst notes on MRX yet.
Members whose judged calls on MRX have played out most reliably.
No settled calls on MRX yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice
Analyst Ratings
8 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 5 | 1 | 0 | 0 | Buy1.78 |
| 1 mo ago | 3 | 4 | 1 | 0 | 0 | Buy1.75 |
| 2 mo ago | 3 | 4 | 1 | 0 | 0 | Buy1.75 |